Published November 15, 2012
Intarcia Therapeutics said it raised $210 million, enabling the biotechnology company to fund late-stage clinical trials for a new diabetes treatment without forming an alliance with a major drug maker. [ read more ]
Utah Business Social
Sustainable Business Awards Nov 19, 2015Utah Business magazine is pleased to announce the Utah Sustainable Business Awards. This program ...